AsymmetRx Sues Rivals Over Cancer Diagnostic Test
Drug development and medical device company AsymmetRx Inc. filed suit against a group of rival diagnostic companies Wednesday, claiming they are infringing two of its patents describing certain antibodies used to...To view the full article, register now.
Already a subscriber? Click here to view full article